Atypical X-linked ichthyosis in a patient with a large deletion involving the steroid sulfatase (STS) gene

International Journal of Dermatology

Volumn 48, Issue 2, 2009, Pages 142-144

  Gonzalez Huerta, Luz ^a   Mendiola Jimenez, Jaime ^a   Del Moral Stevenel, Maria ^a   Rivera Vega, Maria ^a   Cuevas Sovarrubias, Sergio ^a  

^a UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL SULFATE; EMOLLIENT AGENT; GENE PRODUCT; STERYL SULFATASE; UNCLASSIFIED DRUG; VARIABLE CHARGE X LINKED 3A PROTEIN;

AGED; ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE SEVERITY; GENE ACTIVITY; GENE DELETION; GENETIC ASSOCIATION; HUMAN; MALE; MARKER GENE; ONSET AGE; PATHOGENESIS; POLYMERASE CHAIN REACTION; SKIN DEFECT; SKIN MANIFESTATION; X LINKED ICHTHYOSIS;

AGED; FAMILY HEALTH; GENE DELETION; HUMANS; ICHTHYOSIS, X-LINKED; LEG; MALE; SEVERITY OF ILLNESS INDEX; SKIN; STERYL-SULFATASE;

EID: 59149090751     PISSN: 00119059     EISSN: 13654632     Source Type: Journal    
DOI: 10.1111/j.1365-4632.2009.03996.x     Document Type: Article

References (10)

1. Costagliola C, Fabbrocini G, Illiano GM, et al. Ocular findings in X-linked ichthyosis: A survey on 38 cases. Ophthalmologica 1991; 3: 152-155.
2. Ingordo V, D'Andria G, Gentile C, et al. Frequency of X-linked ichthyosis in coastal southern Italy: A study on a representative sample of a young male population. Dermatology 2003; 207: 148-150.
3. Reed MJ, Purohit A, Woo LW, et al. Steroid sulfatase: Molecular biology, regulation, and inhibition. Endocr Rev 2005; 26: 171-202.
4. Aviram-Goldring A, Goldman B, Netanelov-Shapira I, et al. Deletion patterns of the STS gene and flanking sequences in Israeli X-linked ichthyosis patients and carriers: Analysis by polymerase chain reaction and fluorescence in situ hybridization techniques. Int J Dermatol 2000; 39: 182-187.
5. Jimenez Vaca AL, Valdes-Flores Mdel R, Rivera-Vega MR, et al. Deletion pattern of the STS gene in X-linked ichthyosis in a Mexican population. Mol Med 2001; 7: 845-849.
6. Van Esch H, Hollanders K, Badisco L, et al. Deletion of VCX-A due to NAHR plays a major role in the occurrence of mental retardation in patients with X-linked ichthyosis. Hum Mol Genet 2005; 14: 1795-1803.
7. Kawabe S, Ikuta T, Ohba M, et al. Cholesterol sulfate activates transcription of transglutaminase 1 gene in normal human keratinocytes. J Invest Dermatol 1998; 111: 1098-1102.
8. Nemes Z, Demeny M, Marekiv LN, Fesus L, Steinert PM. Cholesterol 3-sulfate interferes with cornified envelope assembly by diverting transglutaminase 1 activity from the formation of cross-links and esters to the hydrolysis of glutamine. J Biol Chem 2000; 28: 2636-2646.
9. Elias PM, Crumrine D, Rassner U, et al. Basis for abnormal desquamation and permeability barrier dysfunction in RXLI. J Invest Dermatol 2004; 122: 314-319.
10. Liao H, Waters AJ, Goudie DR, et al. Filaggrin mutations are genetic modifying factors exacerbating X-linked ichthyosis. J Invest Dermatol 2007; 127: 2795-2798.